Healome Therapeutics Secures £2M to Advance Eye Drop Technology
BIRMINGHAM, United Kingdom, July 7, 2026 Healome Therapeutics, a University of Birmingham spinout developing an innovative eye-drop matrix technology...
capital markets
Advertisement
Regal Healthcare Capital Closes $610 Million Fund IV
NEW YORK, July 7, 2026 Regal Healthcare Capital Partners has successfully completed the final close of Fund IV, securing...
BMS to Spotlight Pipeline at TD Cowen Health Meet
NEW YORK, Feb. 24, 2026 — Bristol Myers Squibb announced its participation in the upcoming TD Cowen 46th Annual...
HCW Biologics Prices $1.5M Follow-On Offering
MIRAMAR, FLORIDA, UNITED STATES — February 17, 2026 HCW Biologics announced the pricing of a $1.5 million follow-on public...
Cardiol Raises $13.5M to Advance Late-Stage Heart Drug Trials
Toronto, Ontario, January 16, 2026 — Cardiol Therapeutics announced a bought deal private placement financing for gross proceeds of...
Advertisements
Contineum Secures $90M Funding to Advance CNS Drug Pipeline
BOSTON, December 12, 2025 — Contineum Therapeutics, Inc. announced the pricing of an upsized $90.0 million public offering of...
FDA Grants Priority Review to AstraZeneca’s Baxdrostat NDA for Hard-to-Control Hypertension
Cambridge, UK & Wilmington, Delaware, December 2025 — AstraZeneca has announced that the U.S. Food and Drug Administration has...
Formosa Licenses Ophthalmic Clobetasol Suspension to Rxilient for Asia Commercialization
Taipei, Taiwan, December 2025 — Formosa Pharmaceuticals has announced a licensing agreement with Rxilient Biotech to commercialize clobetasol propionate...
Kazia Therapeutics Secures $50M Private Placement to Strengthen Pipeline Funding
Sydney, Australia, December 3, 2025 — Kazia Therapeutics has announced the pricing of a US $50 million private placement...
BYT Launches NCIB Amid AGM Results to Strengthen Corporate Outlook
Vancouver, British Columbia — December 2, 2025 — BYT Holdings Ltd. announced its plan to initiate a Normal Course...
Advertisement
